Approval · Notice of Compliance 29360 · 2022
OMNITROPE: Notice of Compliance 29360
Issued November 1, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29360
- Date
- November 1, 2022
- Company
- Sandoz Canada Inc.Saint-Hubert, Quebec, Canada
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph update
- Canadian reference product
- GENOTROPIN
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| OMNITROPE | Not yet assigned | — |
Medicinal ingredients
- SOMATROPIN 5.8 MG per VIAL
- STERILE WATER 1.14 ML per CART
- SOMATROPIN 5 MG per 1.5ML
- SOMATROPIN 10 MG per 1.5ML
- SOMATROPIN 15 MG per 1.5ML